Truist Financial
TNDM icon

Truist Financial’s Tandem Diabetes Care TNDM Stock Holding History

Truist Financial’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$458K Sell
30,319
-300
-1% -$5.24K ﹤0.01% 2257
2026
Q1 		$587K Buy
30,619
+2,448
+9% +$53.2K ﹤0.01% 1986
2025
Q4 		$619K Sell
28,171
-87,405
-76% -$1.58M ﹤0.01% 1922
2025
Q3 		$1.4M Sell
115,576
-7,955
-6% -$108K ﹤0.01% 1522
2025
Q2 		$2.3M Sell
123,531
-15,016
-11% -$297K ﹤0.01% 1206
2025
Q1 		$2.65M Buy
138,547
+18,986
+16% +$556K ﹤0.01% 1091
2024
Q4 		$4.31M Buy
119,561
+2,434
+2% +$82.3K 0.01% 899
2024
Q3 		$4.97M Buy
117,127
+7,900
+7% +$335K 0.01% 833
2024
Q2 		$4.4M Sell
109,227
-4,300
-4% -$179K 0.01% 911
2024
Q1 		$4.02M Buy
113,527
+26,043
+30% +$698K 0.01% 970
2023
Q4 		$2.59M Buy
+87,484
New +$1.81M ﹤0.01% 1134
2023
Q2 		– Sell
-7,190
Closed -$292K – 2679
2023
Q1 		$292K Buy
+7,190
New +$298K ﹤0.01% 2259
2022
Q4 		– Sell
-4,625
Closed -$221K – 2680
2022
Q3 		$221K Buy
+4,625
New +$254K ﹤0.01% 2255
2022
Q2 		– Sell
-2,096
Closed -$244K – 2777
2022
Q1 		$244K Hold
2,096
– – ﹤0.01% 2435
2021
Q4 		$315K Buy
2,096
+171
+9% +$23.1K ﹤0.01% 2326
2021
Q3 		$230K Buy
+1,925
New +$212K ﹤0.01% 2495
2021
Q1 		– Sell
-3,454
Closed -$330K – 2728
2020
Q4 		$330K Sell
3,454
-2,977
-46% -$307K ﹤0.01% 2101
2020
Q3 		$730K Buy
6,431
+1,418
+28% +$149K ﹤0.01% 1517
2020
Q2 		$495K Buy
5,013
+587
+13% +$46.8K ﹤0.01% 1628
2020
Q1 		$284K Buy
4,426
+388
+10% +$27.2K ﹤0.01% 1894
2019
Q4 		$240K Buy
+4,038
New +$249K ﹤0.01% 2272

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Truist Financial's TNDM Position: Q2 2026 in Review

Truist Financial reduced its Tandem Diabetes Care (TNDM) stake by 0.98% in Q2 2026, selling an estimated $5.24K and leaving 30,319 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #2257.

Truist Financial first reported a position in TNDM in Q4 2019 and has held it in 21 quarters since. The position peaked at $4.97M in Q3 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Truist Financial held 30,319 shares of Tandem Diabetes Care worth $458K as of Q2 2026.
  • Truist Financial sold 300 Tandem Diabetes Care shares in Q2 2026, an estimated $5.24K.
  • Tandem Diabetes Care made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2257 holding.
  • Truist Financial first reported a position in Tandem Diabetes Care in Q4 2019 and has held it in 21 quarters since.
  • Truist Financial's Tandem Diabetes Care position peaked at $4.97M in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.